STOCK TITAN

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Revenue by Year

LFMDP

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock generated $194.1M in revenue in fiscal year 2025. This represents an increase of 25.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $191.6M in revenue. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock has filed alongside them.

FY2025 annual
Revenue $194.1M
YoY +25.3%
5Y CAGR +39.1%
10Y CAGR +66.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LFMDP Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Revenue$191.6M$194.1M+25.3%$154.8M+1.5%$152.5M+28.2%$119.0M+28.2%$92.9M+149.0%$37.3M+199.1%$12.5M+49.8%$8.3M+126.1%$3.7M-29.7%$5.2M+329.8%$1.2M+70.7%$714K-11.7%$808K+20.0%$674K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LFMDP Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$47.3M-3.5%$50.2M-1.4%$34.0M+403.7%$60.2M+13.0%$49.0M-3.2%$50.9M+15.3%$6.7M-85.0%$53.3M+38.0%$50.7M+40.9%$44.1M+33.3%$44.9M+59.5%$38.6M+22.9%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock financials

Frequently Asked Questions

What was LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's revenue in fiscal year 2025?

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock generated $194.1M in revenue in fiscal year 2025.

How fast is LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's revenue growing?

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) revenue rose by 25.3% year over year, from $154.8M to $194.1M in fiscal year 2025.

What is LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's revenue over the last twelve months?

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported $191.6M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 14 fiscal years this page covers, LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) revenue went from $674K in fiscal year 2012 to $194.1M in fiscal year 2025.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported $47.3M in revenue in Q2 2026. This represents a decrease of 3.5% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported on that line in every period on record.